Eisai
4523.T
#2012
Rank
HK$62.28 B
Marketcap
HK$220.96
Share price
3.80%
Change (1 day)
-40.27%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): HK$17.10

According to Eisai's latest financial reports the company's current EPS (TTM) is HK$17.00. In 2022 the company made an earnings per share (EPS) of HK$12.48 a decrease over its 2021 EPS that were of HK$55.41.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$17.1036.98%
2022HK$12.48-77.48%
2021HK$55.41-41.88%
2020HK$95.34-0.94%
2019HK$96.2552.59%
2018HK$63.07124.17%
2017HK$28.14-49.42%
2016HK$55.6337.08%
2015HK$40.59-11.75%
2014HK$45.99-3.23%
2013HK$47.52-18.56%
2012HK$58.35-15.51%
2011HK$69.07-3.75%
2010HK$71.76-1.36%
2009HK$72.75